CD22

Jump to: navigation, search
CD22 molecule
Identifiers
Symbol CD22
Entrez 933
HUGO 1643
OMIM 107266
RefSeq NM_001771
UniProt P20273
Other data
Locus Chr. 19 q13.1

CD22 or cluster of differentiation-22, is a molecule belonging to the SIGLEC family of lectins.[1] Generally speaking, CD22 is a regulatory molecule that prevents the overactivation of the immune system and the development of autoimmune diseases.

CD22 is a sugar binding transmembrane protein, which specifically binds sialic acid with an immunoglobulin (Ig) domain located at its N-terminus. The presence of Ig domains makes CD22 a member of the immunoglobulin superfamily. CD22 functions as an inhibitory receptor for B cell receptor (BCR) signalling.

EBV (Ebstein Bar Virus) is known to bind to the B lymphocyte via the CD22 receptor.

An immunotoxin, BL22, that targets this receptor is being tested at the NIH.[1]

External links

References

  1. Crocker P, Clark E, Filbin M, Gordon S, Jones Y, Kehrl J, Kelm S, Le Douarin N, Powell L, Roder J, Schnaar R, Sgroi D, Stamenkovic K, Schauer R, Schachner M, van den Berg T, van der Merwe P, Watt S, Varki A (1998). "Siglecs: a family of sialic-acid binding lectins". Glycobiology 8 (2): v. PMID 9498912.



Navigation WikiDoc | WikiPatient | Popular pages | Recently Edited Pages | Recently Added Pictures

Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs

Editor Tools Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Permanent link | Maintain Pages | What Pages Link Here
There is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies
Linked-in.jpg
Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox